Back to Search
Start Over
Glycoprotein 130 Inhibitor Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.
- Source :
-
The Canadian journal of cardiology [Can J Cardiol] 2016 Nov; Vol. 32 (11), pp. 1356.e1-1356.e10. Date of Electronic Publication: 2016 Feb 23. - Publication Year :
- 2016
-
Abstract
- Background: Pulmonary arterial hypertension (PAH) is characterized by vasoconstriction, vascular remodelling, and microthrombotic events. Inflammatory cytokine interleukin (IL-6) may be a key factor in the development of PAH, and glycoprotein 130 (Gp130) is an important signal-transducing subunit of IL-6. The aim of our study was to evaluate the effectiveness of Gp130 inhibitor in reducing inflammation and ameliorating PAH-related vascular remodelling in monocrotaline (MCT)-exposed rats.<br />Methods: Sprague-Dawley rats (n = 96; weight, 240-250 g) were randomly divided into 3 groups: control, MCT-exposed (MCT), and MCT-exposed plus Gp130 inhibitor (MCT-Gp) administered daily (5 mg/kg) from days 14-28. Eight rats were killed in each group at weeks 1 through 4, with the following measured variables compared across groups on day 28: hemodynamics, right ventricular hypertrophy, morphometric measurements, immunohistochemical results, levels of IL-6, phosphorylated signal transducer and activator of transcription 3, proliferating cell nuclear antigen (PCNA), bone morphogenetic protein receptor-2 (BMPR2), proangiogenic factor, vascular endothelial growth factor (VEGF), proproliferative kinase extracellular signal-regulated kinase (ERK), survivin, Bcl-2, and Bax.<br />Results: Compared with the MCT group, Gp130 inhibitor, after MCT exposure, improved hemodynamics and significantly reduced the severity of inflammation, as estimated by levels of IL-6 (P < 0.0001), and reversed pulmonary arterial remodelling, as assessed by medial wall thickness (P < 0.0001). Gp130 inhibitor upregulated BMPR2 expression in MCT-exposed lungs (P = 0.040) and decreased the expression of PCNA, VEGF, ERK, and survivin (all P < 0.05).<br />Conclusions: Gp130 inhibitor upregulated BMPR2 expression in MCT-exposed lungs, restored the BMPR2/IL-6 balance, reduced IL-6-associated inflammation, inhibited pulmonary artery smooth muscle cell proliferation, and ameliorated pulmonary vascular remodelling in MCT-induced PH in rats.<br /> (Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Bone Morphogenetic Protein Receptors, Type II metabolism
Cytokines metabolism
Extracellular Signal-Regulated MAP Kinases metabolism
Lung metabolism
Microtubule-Associated Proteins metabolism
Monocrotaline toxicity
Proliferating Cell Nuclear Antigen metabolism
Pulmonary Artery drug effects
Pulmonary Artery pathology
Rats, Sprague-Dawley
Survivin
Up-Regulation
Vascular Endothelial Growth Factor A metabolism
Glycoproteins antagonists & inhibitors
Hypertension, Pulmonary drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1916-7075
- Volume :
- 32
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- The Canadian journal of cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 27160963
- Full Text :
- https://doi.org/10.1016/j.cjca.2016.02.058